The FDA record for K260403 identifies 7D Surgical ULC, Toronto, Ontario, as the applicant for the 7D Surgical System (10-0001), a Class II device under 21 CFR 882.4560, product code OLO, with a substantially equivalent decision dated October 19, 2026. The same record lists the device as an orthopedic stereotaxic instrument in the neurology advisory committee, and the clearance letter describes an Open Spine Module for image-guided surgical navigation. [1][2]
The K260403 clearance and its scope
K260403 was received February 6, 2026, reviewed as a Traditional submission without third-party review, and decided October 19, 2026 as substantially equivalent. The FDA database entry names the device 7D Surgical System (10-0001) and lists a summary as the statement type. The clearance letter carries the same regulation number and product code and describes the subject as an Open Spine Module for image-guided surgical navigation, with additional features noted. [1][2]
The applicant address on both the database entry and the letter is 60 Scarsdale Rd., Unit 118, Toronto, Ontario M3B 2R7, Canada, with Elena Marenny listed as senior regulatory specialist. That address is a filing contact location, not a verified headquarters. The letter is dated October 19, 2026 and records a submission dated and received September 18, 2026. [1][2]
Earlier percutaneous navigation filing
A 2022 clearance letter for K220522 names the 7D Surgical System - Percutaneous Application (7D Flash Frame) under the same regulation number, 21 CFR 882.4560, Class II, product code OLO, with a decision dated May 20, 2022. The accompanying submission text identifies 7D Surgical, Inc. at the same Toronto address and lists Daniel Ziskind as director of quality and regulatory, with a preparation date of February 22, 2022. [6]
Read together, the two letters document a device family spanning percutaneous and open spine navigation applications under one regulation and product code. The 2022 letter names a distinct trade designation, the 7D Flash Frame, while the 2026 letter names the 7D Surgical System (10-0001). Neither letter establishes commercial availability, installed base or clinical performance. [2][6]
Adverse event reports in the record set
Four MAUDE adverse event report pages in the record set name 7D Surgical ULC and the 7D Surgical System, with device descriptions given as navigation system or stereotaxic surgery system under product code OLO. The pages identify the reports by MDR FOI identifiers but the retrieved text does not include event narratives, dates, patient details or outcomes. [4][5][7][8]
A fifth MAUDE page carries the same manufacturer and device naming. Because the retrieved content is limited to page framing, the record set does not support conclusions about event frequency, severity, causality or comparison with other devices. The absence of recall records in the collection is likewise not evidence of safety performance. [9]
How to read the collection counts
The linked-record collection contains one 510(k) record, and the decision count for that full collection is one substantially equivalent decision. The smaller record sample also contains one record with one substantially equivalent decision. These are counts of the filings assembled as of November 20, 2026, not totals for company sales, the full product portfolio or safety history. [1]
The FDA premarket notification database page for K260403 appears in the record set only as navigational page framing, without substantive device detail. Product identity and regulatory facts therefore rest on the database entry and the clearance letters rather than on that page. [3]

